肺癌中的离子通道:生物和临床相关性
Chiara Capitani1,2, Ginevra Chioccioli Altadonna1,2, Michele Santillo1,2
1General Pathology Laboratory, Department of Experimental and Clinical Medicine, Internal Medicine Section, University of Florence, Florence, Italy.
Frontiers in pharmacology
|November 9, 2023
概括
离子通道在肺癌中发生变化,为新的诊断和治疗策略提供了潜力. 针对这些膜蛋白可以改善非小细胞肺癌和小细胞肺癌患者的结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物物理学的生物物理.
背景情况:
- 肺癌仍然是一个重大的全球健康挑战,有各种各样的亚型,如腺癌和小细胞肺癌.
- 目前肺癌的治疗方法包括手术,放射和化疗,需要新的诊断和治疗生物标志物.
- 在过去的三十年里,人们观察到离子通道在肺癌细胞系和瘤中过度表达.
研究的目的:
- 审查离子通道在非小细胞肺癌和小细胞肺癌中的作用和临床相关性.
- 探索离子通道作为肺癌诊断和治疗点的潜力.
- 总结有关离子通道的当前知识,包括,,,化物,阳离子和尼古丁酸乙胆受体.
主要方法:
- 对肺癌中离子通道研究的文献综述.
- 在肺癌细胞系和原发性瘤中分析离子通道表达模式.
- 对离子通道对诊断和治疗的临床相关性的评估.
主要成果:
- 改变的离子通道表达特征是肺癌的标志.
- 离子通道通常位于等离子膜上,可用于检测和治疗干预.
- 特定的离子通道家族,包括,,,化物,阳离子和尼古丁酸乙胆受体,都与肺癌有关.
结论:
- 离子通道代表了肺癌诊断的有希望的生物标志物.
- 用药物或抗体准离子通道为肺癌提供了一个潜在的治疗策略.
- 对离子通道功能和表达的进一步研究对于肺癌的临床应用至关重要.
更多相关视频
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
10.6K
07:39The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues
Published on: June 16, 2018
9.3K
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
